Coya Therapeutics, Inc. (COYA) vs Insight Molecular Diagnostics Inc. (IMDX)
A side-by-side comparison of Coya Therapeutics, Inc. and Insight Molecular Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COYA
Coya Therapeutics, Inc.
$4.87HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
IMDX
Insight Molecular Diagnostics Inc.
$3.40HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — COYA vs IMDX
growth of $100 · dividends reinvested · last 4yCOYA +6.1% (+1.5%/yr)IMDX -38.8% (-11.6%/yr)COYA compounded faster over this window
COYA IMDX
COYA vs IMDX: by the numbers
- •COYA is the larger company ($114M vs $110M market cap).
- •Both run net losses; COYA's is the smaller (-270.22% vs -2955.63% net margin).
Metrics side by side
Valuation
| Metric | COYA | IMDX |
|---|---|---|
| P/S ratio | 14.25 | 65.74 |
| P/B ratio | 0.00 | N/A |
Profitability
| Metric | COYA | IMDX |
|---|---|---|
| Gross margin | 99.91% | 11.17% |
| Operating margin | -255.05% | -754.08% |
| Net margin | -270.22% | -2955.63% |
| ROE | -0.05% | N/A |
| ROIC | -0.05% | -223.06% |
Growth (annualized)
| Metric | COYA | IMDX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 27.24% |
| Total return CAGR (5Y) | N/A | -44.39% |
Go deeper
Dig into the metrics
Coya Therapeutics ROEInsight Molecular Diagnostics ROECoya Therapeutics operating marginInsight Molecular Diagnostics operating marginCoya Therapeutics revenue growthInsight Molecular Diagnostics revenue growthCoya Therapeutics free cash flowInsight Molecular Diagnostics free cash flow
Coya Therapeutics & Insight Molecular Diagnostics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.